L’hôpital Paul-Brousse est un hôpital du GHU Assistance publique - hôpitaux de Paris - Université Paris-Saclay situé à Villejuif.

During the past decade, Hopital Paul Brousse conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 10 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 6 clinical trials were completed. i.e. 24% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Paul Brousse" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 16 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Gilead Sciences" with 6 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored and "Gustave Roussy, Cancer Campus, Grand Paris" with 3 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Paul Brousse" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Biocompatibles UK Ltd" with 2 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Paul Brousse" are "Colorectal Cancer" (5 trials), "HIV Infections" (5 trials), "Metastatic Colorectal Cancer" (5 trials), "Hepatocellular Carcinoma" (4 trials) and "Liver Transplantation" (4 trials). Many other conditions were trialed in "Hopital Paul Brousse" in a lesser frequency.

Most popular intervention types in "Hopital Paul Brousse" are "Drug" (62 trials), "Procedure" (16 trials), "Other" (13 trials), "Biological" (10 trials) and "Device" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "fluorouracil" (7 trials), "leucovorin calcium" (4 trials), "oxaliplatin" (4 trials) and "JNJ-56136379" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Paul Brousse" are 102 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Paul Brousse". 2 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Hopital Paul Brousse, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Paul Brousse, 5 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 23 trials that are defined as “Not Applicable".